CFTR and cystic fibrosis: Using the FIS assay to measure CFTR-dependent fluid secretion, it was found that triple therapy rescued CFTR function in 12 organoids with 11 unique CF genotypes, identifying additional rare variants with potential clinical benefit for this modulator therapy.